Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis (Q26795648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mario Cazzola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Clive Page

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Josè Jardim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alexander G Chuchalin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Maria Gabriella Matera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

European Respiratory Review

23 February 2020

published in

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

451-461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

Introduction to Meta-Analysis

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Defining phenotypes in COPD: an aid to personalized healthcare.

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Clinical phenotypes of COPD: identification, definition and implications for guidelines

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

N-acetylcysteine in COPD may be beneficial, but for whom?

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Meta-methodology: conducting and reporting meta-analyses

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Chronic bronchitis. Correlation of morphologic findings to sputum production and flow rates

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Definition, epidemiology and natural history of COPD.

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Benefits of high-dose N-acetylcysteine to exacerbation-prone patients with COPD.

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

Retrieving clinical evidence: a comparison of PubMed and Google Scholar for quick clinical searches

1 reference

https://api.crossref.org/works/10.1183%2F16000617.00002215

7 January 2021

10.1183/16000617.00002215

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26324807%20AND%20SRC:MED&resulttype=core&format=json